share_log

Susquehanna Maintains Negative on RXO, Lowers Price Target to $12

Benzinga ·  Nov 12 23:31  · Ratings

Susquehanna analyst Bascome Majors maintains RXO (NYSE:RXO) with a Negative and lowers the price target from $16 to $12.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment